HIV and AIDS Trial, Recruiting (NCT05165745)

HIV and AIDS Trial, Recruiting NCT05165745 Sponsor: Columbia University Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT05165745 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Cisgender women and transgender individuals who have a reason to be offered HIV prevention medication (PrEP), and who have either decided to take PrEP, decided not to take PrEP, or decided to stop taking PrEP

Who may not be able to join:

People who are unable to give informed consent (meaning they are unable to formally agree to participate after being given full information about the trial)
People who are currently living with HIV

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Magdalena Sobieszczyk, MD, MPH, Columbia University

Phone: 2123052201

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05165745

Sponsor: Columbia University

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 2123052201

More information: https://clinicaltrials.gov/study/NCT05165745

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Cisgender women and transgender individuals who have a reason to be offered HIV prevention medication (PrEP), and who have either decided to take PrEP, decided not to take PrEP, or decided to stop taking PrEP

Who may not be able to join:

People who are unable to give informed consent (meaning they are unable to formally agree to participate after being given full information about the trial)
People who are currently living with HIV

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Columbia University

Registry

ClinicalTrials.gov

Start date

25 October 2021

Est. completion

25 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Correlation Between PrEP modality preference and PrEP initiation/persistence in care; PrEP Measurement Preferences Scale Score; Percentage of participants on PrEP who remain engaged in sexual health care

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov